ConductScience.org, home

Paper560239

The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.

Höllt V and 2 others. Brain Res, 1977. Cited by 83 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain. Papers, record 560239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/560239

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.
PubMed
Journal
Brain Res
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
83
iCite
Relative citation ratio, by iCite
3.79
iCite
Revised in PubMed
2019-06-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Höllt VV
2Czlonkowski AA
3Herz AA

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BrainMajor topic
Receptors, DrugMajor topic
Tranquilizing AgentsMajor topic
Animals
Apomorphine
Catalepsy
Chlorpromazine
Dibenzocycloheptenes
Dopamine
Haloperidol
Humans
Male
Mice
Piribedil
Quinolizines
Receptors, Dopamine
Spiperone
Structure-Activity Relationship

Source PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.

PMIDTitleJournalYearIn PapersSource
6,112,768Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6112768PubMed
4,040,216Effects of discriminant and non-discriminant dopamine antagonists on in vivo accumulation of 3H-N-propyl-norapomorphine in mouse striatum and tuberculum olfactorium.Naunyn Schmiedebergs Arch Pharmacol1985https://conductscience.org/library/papers/4040216PubMed
3,873,656Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/3873656PubMed
2,968,911PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.Eur J Nucl Med1988https://conductscience.org/library/papers/2968911PubMed
2,882,801Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperone.Br J Pharmacol1987https://conductscience.org/library/papers/2882801PubMed
1,678,266Difference in in vivo receptor binding between [3H]N-methylspiperone and [3H]raclopride in reserpine-treated mouse brain.J Neural Transm Gen Sect1991https://conductscience.org/library/papers/1678266PubMed
658,293Specific in vivo binding of d-LSD in rat brain.Experientia1978https://conductscience.org/library/papers/658293PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/560239

GET https://conductscience.org/api/papers/v1/560239/authors